PFE stock continues to drop as lung cancer trial disappointment overshadows Ibrance win

PFE stock continues to drop as lung cancer trial disappointment overshadows Ibrance win  MSN

Summary aggregated from MSN's public RSS feed. The full reporting belongs to MSN — please read it on their site.